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Abstract: Tissue engineering aims at resolving problems
such as donor shortage and immune rejection faced by trans-
plantation. Scaffolds (artificial extracellular matrices) have
critical roles in tissue engineering. Recently, we developed
nano-fibrous poly(l-lactic acid) scaffolds under the hypoth-
esis that synthetic nano-fibrous scaffolding, mimicking the
structure of natural collagen fibers, could create a more
favorable microenvironment for cells. This is the first report
that the nano-fibrous architecture built in three-dimensional
scaffolds improved the features of protein adsorption, which
mediates cell interactions with scaffolds. Scaffolds with
nano-fibrous pore walls adsorbed four times more serum
proteins than scaffolds with solid pore walls. More interest-
ingly, the nano-fibrous architecture selectively enhanced
protein adsorption including fibronectin and vitronectin,
even though both scaffolds were made from the same
poly(l-lactic acid) material. Furthermore, nano-fibrous scaf-
folds also allowed 1.7 times of osteoblastic cell attachment
than scaffolds with solid pore walls. These results demon-
strate that the biomimetic nano-fibrous architecture serves
as superior scaffolding for tissue engineering. © 2003 Wiley
Periodicals, Inc. J Biomed Mater Res 67A: 531–537, 2003
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INTRODUCTION
Tissue engineering is a promising approach to re-
solve the problems faced by transplantation including
the shortage of donor tissues (organs) and immune
rejection.1,2 In tissue engineering, the scaffold [artifi-
cial extracellular matrix (ECM)] has critical roles in
supporting cell adhesion, migration, proliferation, dif-
ferentiated function, neo tissue generation, and its
three-dimensional (3D) organization. The scaffold is a
3D substrate for cells, serves as a template for tissue
regeneration, and should finally be replaced by the
cell-produced ECM. To perform these roles, a scaffold
should provide a good 3D microenvironment for cell
attachment, proliferation, and differentiation. Biode-
gradable polymers are attractive candidates because
they degrade after fulfilling the scaffolding function,
eventually leaving nothing foreign in the body.
Collagen is the major component of mammalian
connective tissues. It is found in every major tissue
that requires strength and flexibility such as bone and
skin. Collagen proteins, by definition, are character-
ized by unique triple-helix formation extending over a
large portion of the molecules. So far, approximately
25 distinct collagen alpha chains have been identified,
each encoded by a separate gene.3 The most abundant
is type I. The feature of type I collagen molecule is its
long, stiff, triple-stranded helical structure, in which
three collagen polypeptide chains are wound around
one another in a ropelike superhelix. After being se-
creted into extracellular space, these collagen mole-
cules assemble into higher-order polymers called col-
lagen fibrils, and the fibrils are finally assembled into
collagen fibers with diameters ranging from 50 to 500
nm. Being a major ECM component, type I collagen
has been used extensively in the formulation of bio-
medical materials, especially for soft tissue repair.4
Because of its phylogenetically well-conserved pri-
mary sequence and its helical structure, collagen is
relatively bioinert.5 The use of collagen as a scaffold-
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ing material, however, still remains to be developed to
overcome the concern of pathogen transmission, the dif-
ficulties in handling, and less control over the mechani-
cal properties, biodegradability, and batch-to-batch con-
sistency of natural materials from biological sources.6
One of the major goals of tissue engineering is to
generate tissues/organs mimicking their natural coun-
terparts. One of the best approaches toward “ideal” scaf-
fold design is the biomimetic methodology. The fiber
structure of collagen has long been noticed to be impor-
tant for cell attachment, proliferation, and differentiated
function in tissue culture.7–9 We hypothesized that syn-
thetic nano-fibrous architecture could mimic the ECM
microenvironment. Under this hypothesis, nano-fibrous
materials were developed of synthetic biodegradable
polymers in our laboratory using a phase-separation
technique, to mimic the architecture of collagen.6 More-
over, 3D macroporous architectures have been built in
the nano-fibrous matrices to improve the cell seeding,
distribution, and mass transport.10 In this work, we re-
port nano-fibrous poly(l-lactic acid) (PLLA) scaffolds
with interconnected spherical macropores for tissue en-
gineering applications.
Cell attachment, migration, and growth on the poly-
mer surfaces are believed to be mediated by proteins,
either adsorbed from serum proteins or secreted by
the cells. To evaluate one of the biological properties
of the scaffolds, the protein adsorption to these nano-
fibrous PLLA scaffolds was examined. Cell attach-
ment in relation to the scaffold architecture was also
evaluated.
MATERIALS AND METHODS
Construction of PLLA nano-fibrous polymer
scaffolds
A 12.5% (wt/v) solution of PLLA in a 1:1 (v/v) mixture of
dioxane and pyridine was prepared. Paraffin spheres (0.40 
0.01 g, diameter  250–420 m) were added to Teflon molds
(cylindrical vial with a diameter of 18 mm), and the top
surface of the paraffin was leveled.11 The molds were then
heat-treated at 37°C for 45 min at which time they were
removed and cooled to room temperature. Prepared poly-
mer solution (0.32 mL) was cast onto each paraffin sphere
assembly dropwise and vacuum-treated quickly in a heated
vacuum oven (250 mmHg, 37°C) to remove air trapped
inside the paraffin sphere assemblies. Vacuum treatment in
the heated oven was done as quickly as possible to avoid
further bonding of the paraffin spheres. The polymer solu-
tion (in the paraffin assembly) was phase-separated at
70°C overnight. Then, the vials containing the polymer/
paraffin composite were immersed into cold hexane for 2
days (18°C) to extract the solvent. Next, the composites
were removed from the vials and were cut to the correct
height (1 mm) and diameter (7.2 mm). The composites were
then placed into room temperature hexane to extract the
remaining solvent and to leach the paraffin from the com-
posite. Samples were kept in room temperature hexane for 2
days, changing the hexane three times a day. Hexane was
then exchanged with cyclohexane. The polymer scaffolds
were removed from the cyclohexane, and were frozen
(70°C) for at least 6 h. The frozen scaffolds were then
lyophilized (30 mmHg) at 70°C for 7 days, at 5° to
10°C for 2 days, and dried under the same vacuum pres-
sure at room temperature for 2 days.
Construction of PLLA solid-walled scaffolds
For PLLA solid-walled scaffolds, a 12.5% (wt/v) solution
of PLLA in dioxane was prepared. The paraffin sphere mold
preparation and the polymer casting procedure were per-
formed in the same way as for the nano-fibrous scaffolds.
After polymer casting, the polymer/paraffin composites
were dried under low vacuum overnight (340 mmHg),
and under high vacuum (30 mmHg) for 4 days. Samples
were removed from the vials and cut to the correct height (1
mm) and diameter (7.2 mm). Paraffin leaching and lyophi-
lizing procedures were performed in the same manner as for
nano-fibrous scaffolds.
Protein adsorption to scaffolds
The scaffolds were placed in the protein solutions after
they were completely wetted. To wet the scaffolds, they
were soaked in 100% ethanol for an hour and in phosphate-
buffered saline (PBS) (Gibco BRL, Grand Island, NY) for 30
min twice. During the wetting procedure, they were placed
in a vacuum container to remove air bubbles in the scaffolds.
The scaffolds were then incubated in PBS overnight on a
shaker (25 rpm). The wetted scaffolds were incubated in 25%
human serum, 100 g/mL fibronectin (Sigma, St. Louis,
MO), vitronectin (Biosource International, Carmarillo, CA),
laminin (Sigma), or bovine serum albumin solutions in PBS
for 4 h on the shaker (25 rpm). After the 4 h of incubation,
the scaffold was removed from the protein solution, tapped
on the Whatman paper, and then transferred to a microtube.
The scaffold was washed with 600 L of PBS under gentle
agitation for 5 min. The washing solution was then dis-
carded and 600 L of fresh PBS was replaced to wash again.
A total of three washings was conducted to remove free and
loosely adsorbed proteins (there was a negligible amount of
proteins in the third washing solution). The remaining pro-
teins (adsorbed) on the scaffold were recovered by incuba-
tion in 1% sodium dodecyl sulfate (SDS) solution for 1 h
after homogenization. The procedures were repeated two
more times and the three solutions were pooled in one tube.
The total amount of protein was measured using MicroBCA
assay (Pierce, Rockford, IL).
Western blot analysis for serum fibronectin and
vitronectin adsorbed to the scaffolds
The recovered serum protein samples (25 L of a total of
400 L) were subject to fractionation through 4–12% SDS-
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polyacrylamide gel electrophoresis (PAGE). The fraction-
ated proteins were transferred to a PVDF membrane
(Sigma). The blots were washed with TBST (10 mM Tris-
HCl, 150 mM NaCl, 0.05% Tween-20, pH 8.0), and blocked
with Blotto (5% nonfat milk in TBST) at room temperature
for 1 h. The blots were incubated in anti-human fibronectin
or anti-human vitronectin polyclonal antibodies (Santa Cruz
Biotechnology, Santa Cruz, CA) at room temperature for 1 h.
After washing with TBST, the blots were incubated in anti-
goat immunoglobulin G-horseradish peroxidase-conjugated
antibody (Sigma), and then in chemiluminescence reagent
(SuperSignal West Dura; Pierce). The relative densities of the
protein bands were analyzed with QualityOne (Biorad).
Attachment of MC3T3-E1 cells to the scaffolds
The MC3T3-E1 osteoblasts were cultured in ascorbic acid-
free alpha-Eagle’s minimum essential medium (Quality Biolog-
ical, Gaithersburg, MD) supplemented with 10% fetal bovine
serum (Gibco BRL), 50 U/mL penicillin, and 50 g/mL strep-
tomycin in a humidified incubator at 37°C with a CO2/air ratio
of 5:95. The sterilized solid-walled and nano-fibrous PLLA
scaffolds were soaked in ethanol for 1 h and then exchanged
with PBS three times (30 min each). The scaffolds were then
washed with the alpha-Eagle’s minimum essential medium
containing 10% fetal bovine serum two times (2 h each). Two
million cells were seeded on each scaffold. The cell-scaffold
constructs were cultured on an orbital shaker (75 rpm). After
24 h, the cultured osteoblast-scaffold constructs were washed
with PBS twice (5 min each), and homogenized with tissue
tearer for 1 min at 20,000 rpm. The DNA content was deter-
mined using Hoechst 33258.
Statistical analysis
Student t test was performed, and the difference was
regarded as significant if the p value was 0.05.
RESULTS
Construction of nano-fibrous and solid-walled
PLLA scaffolds
Three-dimensional porous PLLA scaffolds
(height  1 mm, diameter  7.2 mm) were created
with interconnected spherical pores (diameter  250–
420 m). In these studies, the effects of pore wall
architectures were compared. Scaffolds having pore
walls with nano-fibrous architectures (diameter of fi-
bers 50–500 nm) were created by thermally induced
phase separation [Fig. 1(a,b)], and scaffolds having
solid pore walls were created by solvent casting-evap-
oration techniques as previously published11 [Fig.
1(c,d)]. Both the nano-fibrous and solid-walled scaf-
folds had similar porosities of 96% (calculated from
scaffold mass, dimensions, and crystallinity using a
published protocol6) and macro-porous structures.
Protein adsorption from serum to the scaffolds
Both scaffolds were incubated in human or bovine
serum after they were completely wetted. The nano-
fibrous scaffold adsorbed 4.2-fold greater amount of hu-
man serum proteins than the solid-walled scaffold [Fig.
2(A)]. Consistent results were obtained from bovine se-
rum. SDS-PAGE analysis corroborated that greater
amounts of serum proteins were adsorbed to the nano-
fibrous scaffold [Fig. 2(B)]. Moreover, the profile of ad-
sorbed serum proteins to the nano-fibrous scaffold was
different from that to the solid-walled scaffold. Whereas
the intensities of the protein with an approximate size of
150 kDa (arrow) adsorbed to both scaffolds similarly, the
proteins with approximate sizes of 120, 45, or 40 kDa
(arrowheads) exclusively adsorbed onto the nano-fi-
brous scaffold. Based on the measurements of band in-
tensities of proteins, the amounts of proteins adsorbed to
nano-fibrous scaffolds were 0.57–13.35 times those of
corresponding proteins (bands) in control serum,
whereas the amounts of proteins adsorbed to solid-
walled scaffolds were 0.24–0.79 times those of corre-
sponding proteins in the control serum [Table I and Fig.
2(C)]. The ratios of adsorbed amounts of proteins on
nano-fibrous scaffolds to those on solid-wall scaffolds
were always 1.0 and varied drastically with the pro-
teins (Table I). Considering that both scaffolds were
made of the same PLLA material, it was surprising that
nano-fibrous architecture alone could alter the profile of
protein adsorption from serum and showed selectivity.
More interestingly, Western blot analyses showed that
the nano-fibrous scaffolds adsorbed large amounts of
fibronectin and vitronectin from serum, but these cell-
adhesion proteins were barely detected on the solid-
walled scaffolds (Fig. 3). These findings suggested that
nano-fibrous scaffolds might have certain features en-
hancing specific protein-affinity and binding strength.
Adsorption of ECM proteins to the scaffolds
Cell–ECM interactions participate directly in medi-
ating cell adhesion, migration, growth, differentiation,
and apoptosis.12 Adsorption of a few ECM proteins to
nano-fibrous and solid-walled scaffolds was analyzed
to understand the cell behavior on these different scaf-
folds. Prewetted scaffolds were incubated in fibronec-
tin, vitronectin, laminin, or bovine serum albumin
solution. These proteins were adsorbed to the nano-
fibrous scaffolds 2.6–3.9 times higher than to the solid-
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walled scaffolds (Fig. 4). The amounts of different
ECM proteins adsorbed to the nano-fibrous scaffolds
were statistically different among most of the ECM
proteins studied (fibronectin, vitronectin, laminin, and
albumin), with an exception that adsorbed amounts of
vitronectin and albumin were similar. In contrast, the
amounts of these proteins adsorbed to the solid-
walled scaffolds were not statistically different. These
features were consistent with the findings from serum
protein adsorption, suggesting that nano-fibrous scaf-
folds have higher specificity for protein adsorption.
Cell attachment to the scaffolds
In tissue engineering, cell adhesion to a substrate is
critical because adhesion precedes other events such
as cell spreading, cell migration, and often, differenti-
ated cell function. The nano-scaffolds were evaluated
for cell attachment. After 24 h of cell seeding on scaf-
folds pretreated in fetal bovine serum, the amount of
DNAs within a nano-fibrous scaffold was 1.7-fold of
that within a solid-walled scaffold (Fig. 5). Consider-
ing that both scaffolds (nano-fibrous and solid-walled)
have the same macropore structure (interconnected
spherical network) for cell accommodation, this find-
ing suggests that nano-fibrous architecture provides a
more favorable environment for cell attachment.
DISCUSSION
Tissues are made up of cells and ECM. During
tissue development, ECM is secreted and organized
locally by the cells. The ECM serves as a structural
support for cells in the tissue. Also, cell–ECM interac-
tions can directly control cell behavior such as attach-
ment, migration, proliferation, differentiation, and ap-
Figure 1. Scanning electron photomicrographs of nano-fibrous (a,b) and solid-walled (c,d) scaffolds. Original magnification,
	30 (a,c), 	4000 (b,d).
534 WOO, CHEN, AND MA
optosis, modulate the activities of cytokines and
growth factors, and activate intracellular signaling.12
Thus, cell–scaffold (artificial ECM) interactions are
one of the most important issues for tissue-engineer-
ing applications. There has been very active research
on the effects of chemical modification or surface mor-
phology of materials on cell behavior.13,14 Certain bio-
active peptides such as RGD-modified surfaces of
polymer or other materials can enhance cell adhesion
in serum-free culture medium.15,16 The cell behavior
on surfaces with edges, grooves, or other textures is
different from cell behavior on smooth surfaces.14,17
However, these modifications did not exceed the 2D
concept: cells are only attached and interact with a
material surface on one side. Considering that the cell
in vivo contacts and communicates with ECM in three
dimensions, the 3D structure is critical for scaffolds in
tissue engineering. Here, we have demonstrated for
the first time that the nano-fibrous scaffolding archi-
tecture (also having a high porosity and interconnec-
tivity between pores) enhances protein adsorption and
selectivity to certain proteins contributing to cell at-
tachment.
We have also shown that the amount of proteins
adsorbed to nano-fibrous scaffolds was much greater
than that to solid-walled scaffolds. Higher surface-to-
Figure 2. (A) Amount of adsorbed serum proteins to the scaffolds. *Significantly different from solid-walled scaffolds, p 
0.05, n  4. (B) 4–12% polyacrylamide gels stained with Coomassie blue. Lane C, bovine serum proteins; lane S, adsorbed
bovine serum proteins to the solid-walled scaffold; lane N, adsorbed bovine serum proteins to the nano-fibrous scaffold. A
representative result of two independent experiments is shown. (C) Relative intensities of each protein band to serum.
TABLE I









to SolidSolid Nano Solid Nano
1 180 0.036 0.107 0.522 1.551 3.0
2 150 0.041 0.118 0.336 0.967 2.9
3 120 0.008 0.146 0.615 11.354 18.3
4 105 0.003 0.053 0.750 13.250 17.7
5 90 0.015 0.086 0.789 4.526 5.7
6 81 0.080 0.196 0.452 1.107 2.5
7 75 0.057 0.104 0.491 0.897 1.8
8 70 0.443 0.983 0.453 1.004 2.2
9 68 0.121 0.259 0.761 1.629 2.1
10 60 0.063 0.250 0.335 1.330 4.0
11 55 0.152 0.257 0.338 0.571 1.7
12 45 ND 0.111 ND 2.707 —
13 40 ND 0.073 ND 3.042 —
14 26 0.052 0.123 0.333 0.745 2.2
15 25 0.042 0.285 0.241 1.638 2.2
aArbitrary units.
bThe relative band intensity to its corresponding band intensity of serum.
ND, not detected.
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volume ratio of nano-fibrous scaffolds10 may contrib-
ute to enhanced protein adsorption. Interestingly, the
nano-fibrous scaffolds adsorbed a different profile of
proteins from that seen in the solid-walled scaffolds,
even though both scaffolds were made from the same
PLLA material (Figs. 2 and 4). More specific affinities
of certain proteins to the nano-fibrous scaffolds sug-
gest that the nano-fibrous architecture may act as a
selective substrate, enhancing cell–ECM interactions.
In addition to surface-to-volume ratio, the geometry of
nano-fibers, the crystallinity, and orientation of the
polymer could affect the affinities of proteins. All
these factors possibly work together in enhancing pro-
tein adsorption and the specificity to the nano-fibrous
scaffolds.
The unique collagen amino acid sequence forms
three coiled subunits, which wind around each other
in a characteristic right-handed triple helix, forming a
collagen molecule. These molecules pack together
side-by-side to form fibrils, and are further bundled
into collagen fibers varying in diameter from 50 to 500
nm. PLLA has been shown to crystallize into helical
structures.18–20 The helices existing in the synthetic
PLLA nano-fibers may mimic collagen on a molecular
level, and may explain in part the protein adsorption
specificity and enhanced cell attachment.
Most tissue-derived cells are anchorage dependent
and require attachment to a solid substrate for viabil-
ity and growth. For this reason, the initial events that
occur when a cell approaches a substrate are of fun-
damental interest. We showed that nano-fibrous scaf-
folds enhanced cell attachment 1.7-fold. The histology
revealed that the cells adhered on the spherical macro-
pore walls in the scaffolds (data not shown). This
result indicates that both scaffolds, solid-walled and
nano-fibrous, appear to have similar capacity at the
macro and micro scales for cell accommodation even
though the nano-fibrous scaffolds have higher surface
area at the nanometer scale. Thus, it appears that the
nano-fibrous scaffolds provide a more favorable envi-
ronment for cells because of the nano-scaled features.
As mentioned earlier, the cell behaviors appear to be
secondary to adsorption of cell attachment proteins.
The nano-fibrous architecture could increase the cell
attachment to the scaffolds through better protein ad-
sorption, including fibronectin and vitronectin, at least
in part. In addition, nano-fibrous architecture could
alter the mode of anchorage. Filopodia of the cells
were reported to direct to certain particulate struc-
ture.21 The nano-fibrous architecture could allow
filopodia to anchor more tightly, and this mode of
anchorage could also contribute to the adhesion
strength to the nano-fibrous scaffolds.
Figure 3. Western blot for fibronectin (left) and vitronectin
(right). Lane C, control purified fibronectin (1 g) or vitro-
nectin (0.5 g); lane S, adsorbed human serum proteins to
the solid-walled scaffold; lane N, adsorbed human serum
proteins to the nano-fibrous scaffold.
Figure 4. Amounts of adsorbed proteins to the scaffolds.
*Significantly different from solid-walled scaffolds, p  0.05,
n  4.
Figure 5. DNA contents within a construct. *Significantly
different from solid-walled scaffolds, p  0.05, n  4.
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CONCLUSIONS
The newly developed nano-fibrous scaffolds ad-
sorbed greater amounts and a more specific profile of
proteins than the solid scaffolds. The nano-fibrous
scaffolds also enhanced cell attachment. These find-
ings suggest that nano-fibrous architecture in scaffolds
provide a more favorable microenvironment for the
cells, and support our hypothesis that nano-structured
synthetic scaffolding could mimic the cell–ECM mi-
croenvironment.
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